Skip to main content
Equibles
IRD logo

IRD · Opus Genetics, Inc. · Metrics

Track IRD — free

Use IRD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IRD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.27 +0.34 (+8.65%) At close · Nov 4
Russell 2000 member Rebalance outlook locked
Market Cap
$326.96M
Shares
83.20M
Volume · Nov 4 1.16M Avg daily vol (3M) 2.48M

IRD metrics

76 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$4.27
Market cap
$326.96M

Price action

20 metrics
Price change (1W)
+13.6%
Price change (30D)
-10.3%
Price change (3M)
+5.9%
Price change (6M)
-24.4%
Price change (YTD)
+95.5%
Price change (1Y)
+83.6%
Trailing year
Price change (5Y)
-4.8%
52-week high
$6.07
52-week low
$1.74
Change from 52-week high
-35.3%
Change from 52-week low
+125.9%
Annualized volatility
80.6%
Annualized volatility (3M)
95.7%
Beta
1.2
RSI (14D)
47.1
Price vs SMA 50
-11.9%
Price vs SMA 200
-6.4%
Avg volume (3M)
2.48M
Relative volume
0.5
Average dollar volume
$12.36M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
83.20M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
27.7×
reciprocal yield 3.6%
EV / EBITDA
—
EV / EBIT
—
P / sales
33.2×
reciprocal yield 3.0%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
0.0%
P / FCF
—
P / operating cash flow
—
Earnings yield
-32.9%

Historical valuation

8 metrics
P / E historical average (3Y)
4.1×
reciprocal yield 24.7%
P / E historical average (5Y)
4.1×
reciprocal yield 24.7%
EV / revenue historical average (3Y)
6.9×
reciprocal yield 14.5%
EV / revenue historical average (5Y)
10.9×
reciprocal yield 9.2%
EV / EBIT historical average (3Y)
2.3×
reciprocal yield 44.0%
EV / EBIT historical average (5Y)
2.3×
reciprocal yield 44.0%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2023-11-13

Profitability

9 metrics
Gross margin
—
Operating margin
-513.5%
Trailing 12 months
Net margin
-1,091.8%
Gross profit (TTM)
—
Operating profit (TTM)
−$50.61M
Net income (TTM)
−$107.61M
Trailing 12 months
Diluted EPS (TTM)
$-1.33
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.22

Growth

11 metrics
Revenue growth YoY
-73.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$9.86M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+75.8%
Year over year · more shares
Revenue CAGR (3Y)
-29.1%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-115.7%
Debt / equity
—
Current ratio
12.2
EBITDA (TTM)
−$894,662
Free cash flow (TTM)
—
Quick ratio
12.2
Interest coverage
-186.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$53.53M
Latest balance sheet
Cash & equivalents
$88.81M
Total assets
$92.97M
Total debt
$35.28M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$40.67M
Capital expenditures (TTM)
—
R&D (TTM)
$38.62M
SG&A (TTM)
—
Stock compensation (TTM)
$4.46M
R&D / revenue
391.9%
Stock compensation / revenue
45.3%

Ownership (13F)

9 metrics
13F filers
103
13F filer change QoQ
+24
Institutional ownership
69.2%
Conviction holders (share of 13F filers)
1.0%
Crowding (high-turnover and private-fund holders)
50.9%
Private-fund adviser ownership
50.0%
Active holders' share change QoQ
+11.6%
Holder tenure
4.6
Price vs estimated holder cost
+20.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
7.0%

Short interest

3 metrics
Short interest
16.0%
Latest settlement · 7.4 days to cover
Days to cover
7.4d
Short-squeeze score
69 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$3.10M
Insider-sentiment score
8 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1228627 CUSIP 67577R102 13F (30d) 23 filings 23 filers Visit website Investor relations